1-14 of 14
John F. DiPersio
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Conditioning with anti-CD47 and anti-CD117 plus JAK inhibition enables toxic payload-free allogeneic transplantation

Stephen P. Persaud, Aditya R. Yelamali, Julie K. Ritchey, John F. DiPersio
Journal: Blood Advances
Blood Adv (2024) 8 (17): 4502–4506.
https://doi.org/10.1182/bloodadvances.2023012457
Published: 2024
Includes: Supplemental data
Journal Articles

A simplified G-CSF–free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model

Chang Li, Anna K. Anderson, Peter Ruminski, Michael Rettig, Darja Karpova, Hans-Peter Kiem, John F. DiPersio, André Lieber
Journal: Blood Advances
Blood Adv (2024) 8 (15): 4089–4101.
https://doi.org/10.1182/bloodadvances.2024012757
Published: 2024
Includes: Supplemental data
Journal Articles

Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization

Daniel Cancilla, Michael P. Rettig, Darja Karpova, Haresh Thakellapalli, Megh Singh, Marvin J. Meyers, Peter G. Ruminski, Stephanie Christ, Ezhilarasi Chendamarai, Feng Gao, Leah Gehrs, Julie K. Ritchey, Michael Prinsen, John F. DiPersio
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1379–1383.
https://doi.org/10.1182/bloodadvances.2023011653
Published: 2024
Includes: Supplemental data
Journal Articles

Blinatumomab consolidation post–autologous stem cell transplantation in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Armin Ghobadi, Nicole C. Foley, Jared Cohen, Michael P. Rettig, Amanda F. Cashen, Leah Gehrs, Stephanie Christ, Emily Street, Nicholas Wallace, Julie Ritchey, Neha Mehta-Shah, Peter Westervelt, Todd A. Fehniger, Brad Kahl, Nancy L. Bartlett, John F. DiPersio
Journal: Blood Advances
Blood Adv (2024) 8 (3): 513–522.
https://doi.org/10.1182/bloodadvances.2023011130
Published: 2024
Includes: Supplemental data
Journal Articles

Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc

Julie O’Neal, Matthew L. Cooper, Julie K. Ritchey, Susan Gladney, Jessica Niswonger, L. Sofía González, Emily Street, Gabriel J. Haas, Alun Carter, Parmeshwar N. Amayta, Feng Gao, Byung Ha Lee, Donghoon Choi, Melissa Berrien-Elliott, Alice Zhou, Todd A. Fehniger, Mike P. Rettig, John F. DiPersio
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6009–6022.
https://doi.org/10.1182/bloodadvances.2023010032
Published: 2023
Includes: Supplemental data
Journal Articles

Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor

Clinical Trials & Observations
Zachary D. Crees, Michael P. Rettig, Asad Bashey, Steven M. Devine, Samantha Jaglowski, Fei Wan, Amy Zhou, Melinda Harding, Abi Vainstein-Haras, Ella Sorani, Irit Gliko-Kabir, Brenda J. Grossman, Peter Westervelt, John F. DiPersio, Geoffrey L. Uy
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5210–5214.
https://doi.org/10.1182/bloodadvances.2023010407
Published: 2023
Includes: Supplemental data
Journal Articles

Genomic landscape of TP53 -mutated myeloid malignancies

Haley J. Abel, Karolyn A. Oetjen, Christopher A. Miller, Sai M. Ramakrishnan, Ryan B. Day, Nichole M. Helton, Catrina C. Fronick, Robert S. Fulton, Sharon E. Heath, Stefan P. Tarnawsky, Sridhar Nonavinkere Srivatsan, Eric J. Duncavage, Molly C. Schroeder, Jacqueline E. Payton, David H. Spencer, Matthew J. Walter, Peter Westervelt, John F. DiPersio, Timothy J. Ley, Daniel C. Link
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4586–4598.
https://doi.org/10.1182/bloodadvances.2023010156
Published: 2023
Includes: Supplemental data
Journal Articles

Machine learning–based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors

Jingyu Xiang, Min Shi, Mark A. Fiala, Feng Gao, Michael P. Rettig, Geoffrey L. Uy, Mark A. Schroeder, Katherine N. Weilbaecher, Keith E. Stockerl-Goldstein, Shamim Mollah, John F. DiPersio
Journal: Blood Advances
Blood Adv (2022) 6 (7): 1991–2000.
https://doi.org/10.1182/bloodadvances.2021005149
Published: 2022
Includes: Supplemental data
Journal Articles

TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

Clinical Trials & Observations
Jayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, Sarah E. Church, Tressa Hood, Anbarasu Lourdusamy, Michael P. Rettig, Ibrahim Aldoss, Anjali S. Advani, John Godwin, Matthew J. Wieduwilt, Martha Arellano, John Muth, Tung On Yau, Farhad Ravandi, Kendra Sweet, Heidi Altmann, Gemma A. Foulds, Friedrich Stölzel, Jan Moritz Middeke, Marilena Ciciarello, Antonio Curti, Peter J. M. Valk, Bob Löwenberg, Ivana Gojo, Martin Bornhäuser, John F. DiPersio, Jan K. Davidson-Moncada, Sergio Rutella
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5011–5024.
https://doi.org/10.1182/bloodadvances.2020002512
Published: 2020
Includes: Supplemental data
Journal Articles

Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post–allogeneic hematopoietic stem cell transplant patient

Clinical Trials & Observations
Aabha Oza, Michael P. Rettig, Phil Powell, Kathryn O’Brien, David B. Clifford, Julie Ritchey, Leah Gehrs, Julia Hollaway, Eugene Major, Todd A. Fehniger, Christopher A. Miller, Patrick Soon-Shiong, Amy Rock, John F. DiPersio
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2387–2391.
https://doi.org/10.1182/bloodadvances.2019000664
Published: 2020
Journal Articles

A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

Clinical Trials & Observations
Mark A. Schroeder, H. Jean Khoury, Madan Jagasia, Haris Ali, Gary J. Schiller, Karl Staser, Jaebok Choi, Leah Gehrs, Michael C. Arbushites, Ying Yan, Peter Langmuir, Nithya Srinivas, Michael Pratta, Miguel-Angel Perales, Yi-Bin Chen, Gabrielle Meyers, John F. DiPersio
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1656–1669.
https://doi.org/10.1182/bloodadvances.2019001043
Published: 2020
Includes: Supplemental data
Journal Articles

Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1/2 inhibitor ruxolitinib

Clinical Trials & Observations
Scott R. Goldsmith, Sana Saif Ur Rehman, Cara L. Shirai, Kiran Vij, John F. DiPersio
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4131–4135.
https://doi.org/10.1182/bloodadvances.2019000898
Published: 2019
Journal Articles

Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells

Clinical Trials & Observations
Yi-Bin Chen, Jennifer Le-Rademacher, Ruta Brazauskas, Deidre M. Kiefer, Mehdi Hamadani, John F. DiPersio, Mark R. Litzow, Michael Craig, Mitchell E. Horwitz, Andrew S. Artz, Brian L. McClune, Hugo F. Fernandez, Hien Kim Duong, Hati Kobusingye, Mandi Proue, Rebecca J. Drexler, Mary M. Horowitz, Bronwen E. Shaw, John P. Miller, Sakura Hosoba, Edmund K. Waller, Steven M. Devine
Journal: Blood Advances
Blood Adv (2019) 3 (6): 875–883.
https://doi.org/10.1182/bloodadvances.2018027599
Published: 2019
Includes: Supplemental data
Journal Articles

HLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment

Clinical Trials & Observations
Joseph Rimando, Michael Slade, John F. DiPersio, Peter Westervelt, Feng Gao, Chang Liu, Rizwan Romee
Journal: Blood Advances
Blood Adv (2018) 2 (24): 3590–3601.
https://doi.org/10.1182/bloodadvances.2018025437
Published: 2018
Includes: Supplemental data